Barnes Alane P, Chief Legal Officer at Biocryst Pharmaceuticals ($BCRX), sold about $1.5 million in company shares through five open market transactions over the past year. Her latest BCRX insider sale occurred on December 22, 2025. These sales rank her 4,068th among 11,678 insiders by total value, well below the average of $8.6 million per seller across 6.4 trades. She reported no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | M | Common Stock | 150000 | $5.51 | 550,703.0000 | 219,885,000 | 37.43% | 0.07% |
| March 16, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | M | Emp. Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 219,885,000 | 100.00% | 0.07% |
| March 16, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 150000 | $9.15 | 400,703.0000 | 219,885,000 | 27.24% | 0.07% |
| Dec. 22, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 21773 | $7.65 | 398,751.0000 | 219,885,000 | 5.18% | 0.01% |
| Dec. 19, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 16902 | $7.41 | 420,524.0000 | 219,885,000 | 3.86% | 0.01% |
| Dec. 17, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Emp. Stock Option (Right to Buy) | 255050 | $0.00 | 255,050.0000 | 219,885,000 | 9999.99% | 0.12% |
| Dec. 17, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Common Stock | 121700 | $0.00 | 437,426.0000 | 219,885,000 | 38.55% | 0.06% |
| Dec. 15, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 21210 | $7.65 | 315,726.0000 | 219,885,000 | 6.29% | 0.01% |
| Dec. 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 8540 | $7.57 | 336,936.0000 | 219,885,000 | 2.47% | 0.00% |
| Dec. 1, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 91004 | $7.10 | 416,152.0000 | 219,885,000 | 17.94% | 0.04% |
| Dec. 3, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 19770 | $7.65 | 345,476.0000 | 219,885,000 | 5.41% | 0.01% |
| Dec. 1, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | M | Emp. Stock Option (Right to Buy) | 91004 | $0.00 | 0.0000 | 219,885,000 | 100.00% | 0.04% |
| Dec. 1, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | M | Common Stock | 91004 | $3.22 | 507,156.0000 | 219,885,000 | 21.87% | 0.04% |
| Dec. 2, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | S | Common Stock | 50906 | $7.21 | 365,246.0000 | 219,885,000 | 12.23% | 0.02% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Common Stock | 120700 | $0.00 | 415,190.0000 | 206,905,000 | 40.99% | 0.06% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 2461 | $7.39 | 412,729.0000 | 206,905,000 | 0.59% | 0.00% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Emp. Stock Option (Right to Buy) | 250100 | $0.00 | 250,100.0000 | 206,905,000 | 9999.99% | 0.12% |
| Dec. 14, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 8613 | $7.53 | 294,490.0000 | 206,905,000 | 2.84% | 0.00% |
| May 13, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | P | Common Stock | 5000 | $5.53 | 300,762.0000 | 192,198,000 | 1.69% | 0.00% |
| Dec. 19, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 2482 | $6.05 | 293,539.0000 | 185,908,000 | 0.84% | 0.00% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Emp. Stock Option (Right to Buy) | 158500 | $0.00 | 158,500.0000 | 185,908,000 | 9999.99% | 0.09% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | F | Common Stock | 4015 | $6.43 | 296,021.0000 | 185,908,000 | 1.34% | 0.00% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Barnes Alane P | Chief Legal Officer | A | Common Stock | 64000 | $0.00 | 300,036.0000 | 185,908,000 | 27.11% | 0.03% |